Buyback yield (TTM)
1.95%
Shareholder yield (TTM)
3.32%
5Y share count change
34.7%
Buyback spend (TTM)
$565.00M
Cumulative buybacks
$768.00M
Key takeaways
- Xylem (XYL) repurchased about $565.00M of stock over the trailing twelve months.
- Diluted share count is up 34.7% over the last ~5 fiscal years — equity issuance and stock-based compensation are outpacing repurchases.
- TTM buyback ÷ stock-based-comp ratio of 10.46× — repurchases more than cover SBC dilution.
- Cash buyback spend has compounded at -24.5% per year over the latest 5-year window.
- TTM repurchases used about 100% of free cash flow remaining after dividends.
Dividend & buyback yield over time for Xylem (XYL)
Stacked annual yields — buyback yield (TTM cash repurchases ÷ market cap) plus dividend yield from the same fiscal-year-end key-metrics period — show how total cash return per dollar of equity has evolved.
Diluted vs basic shares (annual) for Xylem (XYL)
Diluted weighted-average shares are the EPS denominator — a falling count means buybacks are outpacing SBC dilution.
Year-over-year change in diluted shares for Xylem (XYL)
Green is fewer shares vs the prior fiscal year (net repurchase); red is growth (dilution). The earliest year shown has no prior year to compare.
Cash buyback spend over time for Xylem (XYL)
Latest: $15.00M
Overview
In 2025, Xylem (XYL) buyback spend totalled $15.00M – declined 25.0% year-over-year.
Xylem buyback spend compound annual growth for the 2020–2025 (5 years) window is -24.5%, with a net decline across the window.
Xylem buyback spend plunged from $179.00M in 2015 to $15.00M in 2025, a 91.6% drawdown.
$179.00M stands as the all-time-high annual buyback spend, posted in 2015, against a low of $0.00 during 2009.
Xylem Buyback Spend 2025: $15.00M
Xylem buyback spend in 2025 was $15.00M, declined 25.0% below 2024.
Xylem Buyback Spend 2024: $20.00M
2024's buyback spend for Xylem came in at $20.00M, declined 20.0% below 2023.
Xylem Buyback Spend 2023: $25.00M
Xylem posted buyback spend of $25.00M in 2023, plunged 51.9% below 2022.
Xylem Buyback Spend 2022: $52.00M
In 2022, Xylem reported buyback spend of $52.00M, declined 23.5% below 2021.
Xylem Buyback Spend 2021: $68.00M
Xylem buyback spend in 2021 was $68.00M.
See more financial history for Xylem (XYL).
Buyback, SBC & dilution history
Buyback spend, SBC, net dilution effect, and share count.
| 2025 | $15.00M | $53.00M | −$38.00M | 0.05% | 0.24B | +0.2% | |
| 2024 | $20.00M | $56.00M | −$36.00M | 0.07% | 0.24B | +11.6% | |
| 2023 | $25.00M | $60.00M | −$35.00M | 0.09% | 0.22B | +20.6% | |
| 2022 | $52.00M | $37.00M | $15.00M | 0.26% | 0.18B | -0.3% | |
| 2021 | $68.00M | $33.00M | $35.00M | 0.31% | 0.18B | +0.2% | |
| 2020 | $61.00M | $26.00M | $35.00M | 0.33% | 0.18B | -0.1% | |
| 2019 | $40.00M | $29.00M | $11.00M | 0.28% | 0.18B | +0.1% | |
| 2018 | $59.00M | $30.00M | $29.00M | 0.49% | 0.18B | +0.1% | |
| 2017 | $25.00M | $21.00M | $4.00M | 0.20% | 0.18B | +0.5% | |
| 2016 | $4.00M | $18.00M | −$14.00M | 0.04% | 0.18B | -0.9% | |
| 2015 | $179.00M | $15.00M | $164.00M | 2.75% | 0.18B | -1.4% | |
| 2014 | $134.00M | $18.00M | $116.00M | 1.93% | 0.18B | -1.0% | |
| 2013 | $73.00M | $27.00M | $46.00M | 1.14% | 0.19B | -0.1% | |
| 2012 | $13.00M | $22.00M | −$9.00M | 0.26% | 0.19B | +0.5% | |
| 2011 | $0.00 | $13.00M | −$13.00M | — | 0.19B | +0.4% | |
| 2010 | $0.00 | $9.00M | −$9.00M | — | 0.18B | 0.0% | |
| 2009 | $0.00 | $9.00M | −$9.00M | — | 0.18B | — |
- 2025$15.00M
- 2024$20.00M
- 2023$25.00M
- 2022$52.00M
- 2021$68.00M
- 2020$61.00M
- 2019$40.00M
- 2018$59.00M
- 2017$25.00M
- 2016$4.00M
- 2015$179.00M
- 2014$134.00M
- 2013$73.00M
- 2012$13.00M
- 2011$0.00
- 2010$0.00
- 2009$0.00
Buybacks vs stock-based compensation for Xylem (XYL)
Annual cash repurchases set against stock-based compensation. Coverage above 1× means buybacks fully offset the equity dilution from SBC. TTM coverage: 10.46×.
Buybacks vs dividends (share of cash returned) for Xylem (XYL)
How Xylem splits cash returned to shareholders between dividends and buybacks.
Sector peers by buyback spend
Companies in the same sector as Xylem, ranked by their latest buyback spend.
| $7.55B | |
| $5.19B | |
| $2.68B | |
| $1.86B | |
| $1.14B | |
| $1.13B | |
| $50.00M | |
| $0.00 |
- $7.55B
- $5.19B
- $2.68B
- $1.86B
- $1.14B
- $1.13B
- $50.00M
- $0.00
Buyback capacity (TTM)
Free cash flow minus dividends paid versus actual TTM repurchases — the headroom bar shows how much of post-dividend FCF is still being deployed elsewhere.
Headroom $567.00M (TTM FCF − TTM dividends, clamped at zero).
Frequently asked questions
Data & methodology
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation